ENSG

The Ensign Group Inc
NASDAQHEALTHCAREMEDICAL CARE FACILITIES

Key Statistics

Market Cap
$10.67B
P/E Ratio
28.98
EPS
$6.32
Beta
0.69
52W High
$217.84
52W Low
$141.52
50-Day MA
$166.19
200-Day MA
$182.76
Dividend Yield
0.14%
Profit Margin
6.90%
Forward P/E
23.53
PEG Ratio
1.57

About The Ensign Group Inc

The Ensign Group, Inc. provides health care services in the post-acute care continuum and other ancillary businesses. The company is headquartered in San Juan Capistrano, California.

Official WebsiteUSAFY End: December

Fundamentals

Revenue (TTM)$5.49B
Gross Profit (TTM)$908.93M
EBITDA$582.74M
Operating Margin9.04%
Return on Equity17.00%
Return on Assets5.49%
Revenue/Share (TTM)$95.13
Book Value$42.26
Price-to-Book4.38
Price-to-Sales (TTM)1.95
EV/Revenue2.281
EV/EBITDA20.23
Quarterly Earnings Growth (YoY)16.70%
Quarterly Revenue Growth (YoY)17.30%
Shares Outstanding$58.28M
Float$55.69M
% Insiders3.54%
% Institutions95.17%

Historical Volatility

HV 10-Day
29.89%
HV 20-Day
26.22%
HV 30-Day
29.08%
HV 60-Day
34.40%
HV Rank
65.1%

Volatility is currently expanding

Analyst Ratings

Consensus ($219.00 target)
1
Strong Buy
3
Buy
1
Hold

Latest News

The Ensign Group Q2 Earnings Call Highlights

The Ensign Group NASDAQ: ENSG raised its 2026 earnings and revenue outlook after reporting second-quarter gains in revenue, earnings and occupancy, while highlighting continued acquisition activity and clinical quality measures across its skilled nursing portfolio.

MarketBeat7/29/2026Positive
Kaplan Fox is Investigating The Ensign Group, Inc. (ENSG) and Encourages Investors Who Suffered Losses to Contact the Firm

New York, New York--(Newsfile Corp. - July 29, 2026) - Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against The Ensign Group, Inc. ("Ensign" or the "Company") (NASDAQ: ENSG). CLICK HERE TO RECEIVE MORE INFORMATION ABOUT THIS INVESTIGATION If you are an Ensign investor and have suffered losses, or if you have information that could assist in the Ensign investigation, you may CLICK HERE to contact us.

Newsfile Corp7/29/2026Neutral
ENSG INVESTIGATION: Ensign Securities Fraud Investigation into Regulatory Issues is Ongoing – Contact BFA Law if You Lost Money

NEW YORK, July 29, 2026 (GLOBE NEWSWIRE) -- Leading securities law firm  Bleichmar Fonti & Auld LLP announces an investigation into The Ensign Group, Inc. (NASDAQ:ENSG) for potential securities fraud after significant stock drops. If you invested in Ensign, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases/ensign-class-action-lawsuit.

GlobeNewsWire7/29/2026Neutral
Here's What Key Metrics Tell Us About Ensign Group (ENSG) Q2 Earnings

Although the revenue and EPS for Ensign Group (ENSG) give a sense of how its business performed in the quarter ended June 2026, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

Zacks Investment Research7/27/2026Positive
Ensign Investor News: If You Have Suffered Losses in The Ensign Group, Inc. (NASDAQ: ENSG), You Are Encouraged to Contact The Rosen Law Firm About Your Rights

NEW YORK, July 26, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of The Ensign Group, Inc. (NASDAQ: ENSG) resulting from allegations that Ensign may have issued materially misleading business information to the investing public.

GlobeNewsWire7/27/2026Neutral
ROSEN, SKILLED INVESTOR COUNSEL, Encourages The Ensign Group, Inc. Investors to Inquire About Securities Class Action Investigation - ENSG

New York, New York--(Newsfile Corp. - July 24, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of The Ensign Group, Inc. (NASDAQ: ENSG) resulting from allegations that Ensign may have issued materially misleading business information to the investing public. SO WHAT: If you purchased Ensign securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

Newsfile Corp7/24/2026Neutral
Kaplan Fox Encourages Investors of The Ensign Group, Inc. (ENSG) Who Suffered Losses to Contact the Firm Regarding a Securities Investigation

New York, New York--(Newsfile Corp. - July 24, 2026) - Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against The Ensign Group, Inc. ("Ensign" or the "Company") (NASDAQ: ENSG). CLICK HERE TO RECEIVE MORE INFORMATION ABOUT THIS INVESTIGATION If you are an Ensign investor and have suffered losses, or if you have information that could assist in the Ensign investigation, you may CLICK HERE to contact us.

Newsfile Corp7/24/2026Neutral
Ensign Investor News: If You Have Suffered Losses in The Ensign Group, Inc. (NASDAQ: ENSG), You Are Encouraged to Contact The Rosen Law Firm About Your Rights

NEW YORK, July 23, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of The Ensign Group, Inc. (NASDAQ: ENSG) resulting from allegations that Ensign may have issued materially misleading business information to the investing public.

GlobeNewsWire7/23/2026Neutral

Turn research into an automated options-selling system

Tiblio connects your broker and runs your put-and-call-writing strategy for you — on ENSG and any ticker you trade — then tracks every position and per-strategy win rate.

See how it works

More HEALTHCARE Stocks

Data last updated: 7/29/2026